The global NMR spectrometer market is predicted to witness high volume by 2023, according to a report available on Million Insights. It is anticipated to exhibit a healthy CAGR over the forecast period (2018 to 2023). Increasing use of NMR spectrometers in healthcare industry to produce magnetic resonance imaging is anticipated to propel market growth. The technology is also used to produce metabolic fingerprints from biological liquids. It helps healthcare professionals in gathering essential information regarding toxic insults or disease state. Rising demand for quality analysis of wide range of food products using spectrometers is expected to impel market growth. Growing adoption of hyphenated technology and increasing use of portable instruments is likely to augment market growth. Hyphenated technologies combine spectroscopic techniques to get better qualitative and quantitative analysis of unknown compounds.
Nuclear Magnetic Resonance (NMR) spectrometer is defined as an analytical tool used to exploit magnetic properties of an atomic nuclei. It can explain chemical and physical properties of molecules and atoms. The technology was developed in late 1940 and later 1950 by Bloch Group and Purcell Group at Stanford and Harvard University. It is used in research activities and quality control to samples to determine purity of sample and its molecular structures.
Major application variants of NMR spectrometer are pharmaceutical and biotechnology industries, agriculture and food industries, chemical industry, and oil and gas industry. Biotechnology and pharmaceutical industry segment is predicted to hold highest market share over the forecast period. This is attributed to growth of global challenges and rising adoption of unmatched level of innovation in the field. In addition, advent of new healthcare laws to provide advanced medical services to patients will drive segment’s growth.
To cater to rising demand for NMR spectrometer, manufacturing companies are focusing on R&D activities to develop innovative products. For instance, in April 2019, Bruker launched NMR research and pharma innovations at Experimental Nuclear Magnetic Resonance Conference (ENC). The company has introduced fast and user-friendly iProbe CP-MAS, which is aimed to support automated workflows. Features such as auto-tuning and matching for solid state magic angle spinning experiments, automated magic angle calibration, and support for sample changers. In addition, the device offers optimized results in automation and is available for 400, 500, and 600 megahertz (MHz).
Some of the key players of NMR spectrometer market are Bruker Corporation, Thermo Fisher Scientific, Oxford Instruments, Nanalysis Corporation, and Magritek.